2023-03-012024-02-292024-02-29false05352733PODIATRY FIRST LTD2024-11-2686900iso4217:GBPxbrli:pure053527332023-03-01053527332024-02-29053527332023-03-012024-02-29053527332022-03-01053527332023-02-28053527332022-03-012023-02-2805352733bus:SmallEntities2023-03-012024-02-2905352733bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2905352733bus:FullAccounts2023-03-012024-02-2905352733bus:PrivateLimitedCompanyLtd2023-03-012024-02-2905352733core:WithinOneYear2024-02-2905352733core:AfterOneYear2024-02-2905352733core:WithinOneYear2023-02-2805352733core:AfterOneYear2023-02-2805352733core:ShareCapital2024-02-2905352733core:SharePremium2024-02-2905352733core:RevaluationReserve2024-02-2905352733core:OtherReservesSubtotal2024-02-2905352733core:RetainedEarningsAccumulatedLosses2024-02-2905352733core:ShareCapital2023-02-2805352733core:SharePremium2023-02-2805352733core:RevaluationReserve2023-02-2805352733core:OtherReservesSubtotal2023-02-2805352733core:RetainedEarningsAccumulatedLosses2023-02-2805352733core:LandBuildings2024-02-2905352733core:PlantMachinery2024-02-2905352733core:Vehicles2024-02-2905352733core:FurnitureFittings2024-02-2905352733core:OfficeEquipment2024-02-2905352733core:NetGoodwill2024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2024-02-2905352733core:ListedExchangeTraded2024-02-2905352733core:UnlistedNon-exchangeTraded2024-02-2905352733core:LandBuildings2023-02-2805352733core:PlantMachinery2023-02-2805352733core:Vehicles2023-02-2805352733core:FurnitureFittings2023-02-2805352733core:OfficeEquipment2023-02-2805352733core:NetGoodwill2023-02-2805352733core:IntangibleAssetsOtherThanGoodwill2023-02-2805352733core:ListedExchangeTraded2023-02-2805352733core:UnlistedNon-exchangeTraded2023-02-2805352733core:LandBuildings2023-03-012024-02-2905352733core:PlantMachinery2023-03-012024-02-2905352733core:Vehicles2023-03-012024-02-2905352733core:FurnitureFittings2023-03-012024-02-2905352733core:OfficeEquipment2023-03-012024-02-2905352733core:NetGoodwill2023-03-012024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2905352733core:ListedExchangeTraded2023-03-012024-02-2905352733core:UnlistedNon-exchangeTraded2023-03-012024-02-2905352733core:MoreThanFiveYears2023-03-012024-02-2905352733core:Non-currentFinancialInstruments2024-02-2905352733core:Non-currentFinancialInstruments2023-02-2805352733dpl:CostSales2023-03-012024-02-2905352733dpl:DistributionCosts2023-03-012024-02-2905352733core:LandBuildings2023-03-012024-02-2905352733core:PlantMachinery2023-03-012024-02-2905352733core:Vehicles2023-03-012024-02-2905352733core:FurnitureFittings2023-03-012024-02-2905352733core:OfficeEquipment2023-03-012024-02-2905352733dpl:AdministrativeExpenses2023-03-012024-02-2905352733core:NetGoodwill2023-03-012024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2905352733dpl:GroupUndertakings2023-03-012024-02-2905352733dpl:ParticipatingInterests2023-03-012024-02-2905352733dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2905352733core:ListedExchangeTraded2023-03-012024-02-2905352733dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2905352733core:UnlistedNon-exchangeTraded2023-03-012024-02-2905352733dpl:CostSales2022-03-012023-02-2805352733dpl:DistributionCosts2022-03-012023-02-2805352733core:LandBuildings2022-03-012023-02-2805352733core:PlantMachinery2022-03-012023-02-2805352733core:Vehicles2022-03-012023-02-2805352733core:FurnitureFittings2022-03-012023-02-2805352733core:OfficeEquipment2022-03-012023-02-2805352733dpl:AdministrativeExpenses2022-03-012023-02-2805352733core:NetGoodwill2022-03-012023-02-2805352733core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2805352733dpl:GroupUndertakings2022-03-012023-02-2805352733dpl:ParticipatingInterests2022-03-012023-02-2805352733dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2805352733core:ListedExchangeTraded2022-03-012023-02-2805352733dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2805352733core:UnlistedNon-exchangeTraded2022-03-012023-02-2805352733core:NetGoodwill2024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2024-02-2905352733core:LandBuildings2024-02-2905352733core:PlantMachinery2024-02-2905352733core:Vehicles2024-02-2905352733core:FurnitureFittings2024-02-2905352733core:OfficeEquipment2024-02-2905352733core:AfterOneYear2024-02-2905352733core:WithinOneYear2024-02-2905352733core:ListedExchangeTraded2024-02-2905352733core:UnlistedNon-exchangeTraded2024-02-2905352733core:ShareCapital2024-02-2905352733core:SharePremium2024-02-2905352733core:RevaluationReserve2024-02-2905352733core:OtherReservesSubtotal2024-02-2905352733core:RetainedEarningsAccumulatedLosses2024-02-2905352733core:NetGoodwill2023-02-2805352733core:IntangibleAssetsOtherThanGoodwill2023-02-2805352733core:LandBuildings2023-02-2805352733core:PlantMachinery2023-02-2805352733core:Vehicles2023-02-2805352733core:FurnitureFittings2023-02-2805352733core:OfficeEquipment2023-02-2805352733core:AfterOneYear2023-02-2805352733core:WithinOneYear2023-02-2805352733core:ListedExchangeTraded2023-02-2805352733core:UnlistedNon-exchangeTraded2023-02-2805352733core:ShareCapital2023-02-2805352733core:SharePremium2023-02-2805352733core:RevaluationReserve2023-02-2805352733core:OtherReservesSubtotal2023-02-2805352733core:RetainedEarningsAccumulatedLosses2023-02-2805352733core:NetGoodwill2022-03-0105352733core:IntangibleAssetsOtherThanGoodwill2022-03-0105352733core:LandBuildings2022-03-0105352733core:PlantMachinery2022-03-0105352733core:Vehicles2022-03-0105352733core:FurnitureFittings2022-03-0105352733core:OfficeEquipment2022-03-0105352733core:AfterOneYear2022-03-0105352733core:WithinOneYear2022-03-0105352733core:ListedExchangeTraded2022-03-0105352733core:UnlistedNon-exchangeTraded2022-03-0105352733core:ShareCapital2022-03-0105352733core:SharePremium2022-03-0105352733core:RevaluationReserve2022-03-0105352733core:OtherReservesSubtotal2022-03-0105352733core:RetainedEarningsAccumulatedLosses2022-03-0105352733core:AfterOneYear2023-03-012024-02-2905352733core:WithinOneYear2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2905352733core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2905352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2805352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2805352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2805352733bus:Director12023-03-012024-02-29

PODIATRY FIRST LTD

Registered Number
05352733
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

PODIATRY FIRST LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

S Afzal

Registered Address

41 District Road
Wembley
Middlesex
HA0 2LE

Registered Number

05352733 (England and Wales)
PODIATRY FIRST LTD
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3279328
279328
Current assets
Debtors4134,551166,667
Cash at bank and on hand506499
135,057167,166
Creditors amounts falling due within one year5(112,139)(115,920)
Net current assets (liabilities)22,91851,246
Total assets less current liabilities23,19751,574
Creditors amounts falling due after one year6(13,252)(22,371)
Net assets9,94529,203
Capital and reserves
Called up share capital100100
Profit and loss account9,84529,103
Shareholders' funds9,94529,203
The financial statements were approved and authorised for issue by the Director on 26 November 2024, and are signed on its behalf by:
S Afzal
Director
Registered Company No. 05352733
PODIATRY FIRST LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover represents the total invoice value of services for podiatry related activities.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment15
2.Average number of employees

20242023
Average number of employees during the year33
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 235,4345,434
At 29 February 245,4345,434
Depreciation and impairment
At 01 March 235,1065,106
Charge for year4949
At 29 February 245,1555,155
Net book value
At 29 February 24279279
At 28 February 23328328
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables27,68459,800
Amounts owed by group undertakings106,867106,867
Total134,551166,667
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables10,9079,835
Bank borrowings and overdrafts41,25054,059
Taxation and social security41,15634,910
Other creditors14,02613,516
Accrued liabilities and deferred income4,8003,600
Total112,139115,920
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts13,25222,371
Total13,25222,371
7.Related party transactions
Amounts owed by group undertakings of £106,867 (2023: £106,867) relates to Podiatry First Group Ltd. This is the holding company.